Health & Medicine
-
LifeDNA tweak no good for diabetics
A genetic variation that increases levels of a blood-building protein also ups the risk of developing complications from diabetes.
-
Health & MedicinePotential for protection
A study of U.S. veterans suggests that the anti-inflammatory drug ibuprofen could have a protective effect against Alzheimer’s disease. But researchers say more work is needed.
By Nathan Seppa -
Health & MedicineRice Woes, Pt. 1
A shortfall in rice production has been developing well under the radar screen of agricultural economists and growers. The bad news: It promises to get much worse, and fairly soon.
By Janet Raloff -
EarthIt’s the meat not the miles
Eating less red meat and dairy may do more to reduce food-associated greenhouse gas emissions than shopping locally.
-
Health & MedicineTreat ’em
High blood pressure often goes untreated in people 80 and over, but a new study suggests that treatment extends survival.
By Nathan Seppa -
Health & MedicineMondo bizarro
Psychiatrists measuring the degree of similarity between dreams and psychotic ruminations report some strange features common to both.
By Amy Maxmen -
Health & MedicineFriend or foe? Drunk, the brain can’t tell
Intoxicated brains can’t discern between threatening and safe situations.
-
Health & MedicineLet there be light
Researchers report restoring vision to people with a rare, genetic form of blindness. A different technique helped blind mice see again and could bring back some sight in people with macular degeneration, retinitis pigmentosa or other blinding diseases.
-
Health & MedicineTripping up avian flu
Developing an effective vaccine for avian flu has been difficult, but small rings of DNA that hinder virus replication could offer an alternative.
-
-
Health & MedicinePockets of poor health
Life expectancy decreases in some locations
By Nathan Seppa -
Health & MedicineNew approach might strike at the core of Alzheimer’s disease
By finding a way to stick an enzyme-inhibiting molecule to the membrane of a cell, scientists may have devised the framework for an Alzheimer’s drug.
By Nathan Seppa